(Q36080957)

English

Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

author name string

Wiltschke C

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Krainer M

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Budinsky AC

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Berger A

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Müller C

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Zeillinger R

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Speiser P

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Kubista E

8

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Eibl M

9

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Zielinski CC

10

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

0 references

publication date

1 June 1995

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

71

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1292-1296

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033813

2 October 2017

Steroid receptors and other prognostic factors in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033813

2 October 2017

Tumor grade as a prognostic factor in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033813

2 October 2017

Decreased production of soluble interleukin 2 receptor by phytohaemagglutinin-stimulated peripheral blood mononuclear cells in patients with breast cancer after adjuvant therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033813

2 October 2017

The suppressor-cell network in cancer (second of two parts).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033813

2 October 2017

The CMF program for operable breast cancer with positive axillary nodes:Updated analysis on the disease-free interval, site of relapse and drug tolerance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033813

2 October 2017

Concomitant Presence of Tumor-Specific Cytotoxic and Inhibitor Lymphocytes in Patients with Osteogenic Sarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033813

2 October 2017

Immune status of untreated patients with Hodgkin's disease and prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033813

11 July 2018

Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033813

11 July 2018

Association of increased lytic effector cell function with high estrogen receptor levels in tumor-bearing patients with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033813

11 July 2018

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033813

11 July 2018

Adjuvant tamoxifen in postmenopausal stage II breast cancer five years on.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033813

11 July 2018

Immunocompetence, immunosuppression, and human breast cancer. I. An analysis of their relationship by known parameters of cell-mediated immunity in well-defined clinical stages of disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033813

11 July 2018

Serum-mediated immunosuppression in lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033813

11 July 2018

Impaired primary, but not secondary, immune response in breast cancer patients under adjuvant chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033813

23 September 2018

Reduced lymphocyte transformation in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7779726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/7779726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women

1 reference

https://pubmed.ncbi.nlm.nih.gov/7779726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The occurrence of cancer in immune deficiencies

1 reference

https://pubmed.ncbi.nlm.nih.gov/7779726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune functions and the prognosis of patients with solid tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/7779726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7779726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7779726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation of an immunosuppressive peptide fraction from the serum of cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7779726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1995.250

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36080957&oldid=2198171708"